Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jaquet

Showing results (151-160 of 174) with videos related to

Pageof 18
Sort By:
European Journal of Endocrinology|January 16, 2007
Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's diseaseF Castinetti, M Nagai, H Dufour, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cellsA Saveanu, E Lavaque, G Gunz, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 1999
Expression of the members of the Ptx family of transcription factors in human pituitary adenomasI Pellegrini-Bouiller, C Manrique, G Gunz, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1989
Resistance to bromocriptine in prolactinomasI Pellegrini, R Rasolonjanahary, G Gunz, et al.
Annales D'Endocrinologie|January 1, 1991
[Short-term effect of delayed-action injectable bromocriptine in macroprolactinoma. French multicenter study]T Brue, A James-Deidier, J P Louvet, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1996
Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expressionI Pellegrini-Bouiller, I Morange-Ramos, A Barlier, et al.
European Journal of Endocrinology|July 5, 2005
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapyP Jaquet, G Gunz, A Saveanu, et al.
Journal of Endocrinological Investigation|April 22, 2006
BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotideP Jaquet, G Gunz, A Saveanu, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomasA Saveanu, G Gunz, H Dufour, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1973
Congenital goiter with impaired thyroglobulin synthesisS Lissitzky, J Bismuth, P Jaquet, et al.
Pageof 18

Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
European Journal of Endocrinology|January 16, 2007
Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's diseaseF Castinetti, M Nagai, H Dufour, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cellsA Saveanu, E Lavaque, G Gunz, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 1999
Expression of the members of the Ptx family of transcription factors in human pituitary adenomasI Pellegrini-Bouiller, C Manrique, G Gunz, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1989
Resistance to bromocriptine in prolactinomasI Pellegrini, R Rasolonjanahary, G Gunz, et al.
Annales D'Endocrinologie|January 1, 1991
[Short-term effect of delayed-action injectable bromocriptine in macroprolactinoma. French multicenter study]T Brue, A James-Deidier, J P Louvet, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1996
Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expressionI Pellegrini-Bouiller, I Morange-Ramos, A Barlier, et al.
European Journal of Endocrinology|July 5, 2005
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapyP Jaquet, G Gunz, A Saveanu, et al.
Journal of Endocrinological Investigation|April 22, 2006
BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotideP Jaquet, G Gunz, A Saveanu, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomasA Saveanu, G Gunz, H Dufour, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1973
Congenital goiter with impaired thyroglobulin synthesisS Lissitzky, J Bismuth, P Jaquet, et al.
Pageof 18